East Columbus (Ohio) Surgery Center completed its first iStent inject series, according to Glaukos Corp. Senior Regional Business Manager Andy Wright. 1. Daryl Kaswinkel, MD, performed the procedure.

WILMINGTON, NC (WECT) - A procedure for those with Glaucoma is making it easier to manage the degenerative eye condition on a day-to-day basis. Health officials say glaucoma is the second leading ...

The iStent inject was safe and effective for treating multiple types of primary open-angle glaucoma individually and in conjunction with cataract surgery, according to data published in Journal of ...

Please provide your email address to receive an email when new articles are posted on . This combined procedure provides the benefit of improving vision and decreasing IOP postoperatively, which can ...

Multiple 5-, 6-, 7- and 8-Year Real-World Studies Published, Demonstrating Leading Efficacy & Safety Across the Entire Glaucoma Disease Spectrum SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos ...

Matthew Traynor, MD, successfully completed iStent inject cases at Idaho Falls, Idaho-based Grand Teton Surgery Center, according to Glaukos Corp. Senior Regional Business Manager Jennifer Lee. 1. Dr.

San Clemente-based Glaukos Corp. anticipates strong revenue growth next year for its iStent products, based on a guarantee of reimbursement on procedures that use its iStent implant. Glaukos expects ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

Glaukos Corporation GKOS is gaining on robust product portfolio and iStent technology. However, tough competition has been offsetting the positives to an extent. The company, with a market ...